<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">665</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>SYNTHESIS AND EVALUATION OF ANTIOXIDANT ACTIVITY (IN-VITRO) OF SOME N-PHTHALYL-[{(3-NITRO ANILINO)-4__ampersandsignquot; ARYL SUBSTITUTED}]-1, 3, 4 THIADIAZOLES&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sah</surname><given-names>Pramilla</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sen</surname><given-names>Kuldeep</given-names></name></contrib></contrib-group><volume>)</volume><issue/><fpage>1</fpage><lpage>6</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>1, 3, 4- thiadiazoles are potential bioactive agents having the toxophoric N=C__ampersandsignndash;S linkage. There are several isomers of thiadiazole, i.e.1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, and 1,3,4-thiadiazole. However 1, 3, 4-Thiadiazole is the main isomer of the thiadiazole series which has versatile pharmacological activities. Hence in this study we have synthesized some new substituted 1, 3, 4 thiadiazoles i.e. N-phthalyl-[{(3-nitro anilino)-4__ampersandsignrsquo;__ampersandsignrsquo; aryl Substituted}]-1, 3, 4 thiadiazoles. The title compounds were prepared from N-phthayl-3-nitro anilino thiosemicarbazide by treating N-phthayl-3-nitro aniline with carbon disulphide,&#13;
ammonium hydroxide and hydrazine hydrate. The synthesized compounds were then evaluated for their in- vitro antioxidant activity by determining the reducing power and hydrogen peroxide scavenging potential. The results show that one derivative V2 (N-Phthalyl-[{(3__ampersandsignrsquo;-nitro anilino)-5-(4__ampersandsignrsquo;__ampersandsignrsquo;-chloro phenyl)}]-1, 3, 4-thiadiazole) had the best redusing ability while V4 (N-Phthalyl-[{(3__ampersandsignrsquo;- nitro anilino)-5- (4__ampersandsignrsquo;__ampersandsignrsquo;-bromo phenyl)}]-1, 3, 4-thiadiazole) was the strongest oxidant. The chemical structures of the synthesized compounds have been characterized by IR, 1HNMR and mass spectra.&#13;
</p></abstract><kwd-group><kwd>N-phthalyl</kwd><kwd> 1</kwd><kwd> 3</kwd><kwd> 4-thiadiazoles</kwd><kwd> Antioxidant activity</kwd></kwd-group></article-meta></front></article>
